Literature DB >> 19180563

ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.

Wen-Hsin Liu1, Yun-Ching Cheng, Long-Sen Chang.   

Abstract

The aim of the present study is to explore the signaling pathway associated with Naja naja atra phospholipase A(2) (PLA(2))-induced apoptotic death of human leukemia U937 cells. Degradation of procaspases, production of tBid, loss of mitochondrial membrane potential, and cytochrome c release were observed in PLA(2)-treated cells. PLA(2) treatment increased Fas and FasL protein expression, and upregulated transcription of Fas and FasL mRNA. Upon exposure to PLA(2), ROS generation, p38 MAPK activation, and ERK inactivation were found in U937 cells. Abolition of PLA(2)-induced ROS generation abrogated p38 MAPK activation and upregulation of Fas and FasL expression, but restored ERK activation and viability of PLA(2)-treated cells. Block of p38 MAPK by SB202190 abolished PLA(2)-induced Fas/FasL upregulation and ERK inactivation, but not ROS generation. Activated ERK suppressed p38 MAPK activation and Fas/FasL protein expression. Selective inactivation or overexpression of p38alpha MAPK proved that upregulation of Fas/FasL and ERK inactivation were related to p38alpha MAPK activation. Deprivation of catalytic activity with PLA(2) blocked completely PLA(2)-induced Fas/FasL upregulation. Downregulation of FADD abolished PLA(2)-induced procaspase-8 degradation and rescued viability of PLA(2)-treated cells. Taken together, our results indicate that Fas/FasL upregulation in PLA(2)-treated U937 cells is elicited by ROS-mediated p38alpha MAPK activation and ERK inactivation, and suggest that autocrine Fas/FasL apoptotic mechanism is involved in PLA(2)-induced cell death. J. Cell. Physiol. 219: 642-651, 2009. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19180563     DOI: 10.1002/jcp.21713

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Pseudomonas Quinolone Signal Induces Oxidative Stress and Inhibits Heme Oxygenase-1 Expression in Lung Epithelial Cells.

Authors:  Maher Y Abdalla; Traci Hoke; Javier Seravalli; Barbara L Switzer; Melissa Bavitz; Jill D Fliege; Peter J Murphy; Bradley E Britigan
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

2.  Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.

Authors:  Yunching Chen; Joyeeta Sen; Surendar Reddy Bathula; Qi Yang; Raffaella Fittipaldi; Leaf Huang
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

3.  Mechanical impact induces cartilage degradation via mitogen activated protein kinases.

Authors:  L Ding; E Heying; N Nicholson; N J Stroud; G A Homandberg; J A Buckwalter; D Guo; J A Martin
Journal:  Osteoarthritis Cartilage       Date:  2010-09-09       Impact factor: 6.576

4.  Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment.

Authors:  Hong Seok Kim; Sarah L Ullevig; Debora Zamora; Chi Fung Lee; Reto Asmis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-18       Impact factor: 11.205

5.  Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr-abl oncogene.

Authors:  Weiqi Huang; Ling Bei; Elizabeth A Eklund
Journal:  Leuk Lymphoma       Date:  2012-09-05

6.  Geldanamycin, an inhibitor of Hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis.

Authors:  Qingqing Mo; Yu Zhang; Xin Jin; Yue Gao; Yuan Wu; Xing Hao; Qinglei Gao; Pingbo Chen
Journal:  Tumour Biol       Date:  2016-09-15

7.  The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer.

Authors:  Xin Jin; Qingqing Mo; Yu Zhang; Yue Gao; Yuan Wu; Jing Li; Xing Hao; Ding Ma; Qinglei Gao; Pingbo Chen
Journal:  Cancer Biol Ther       Date:  2016-05-03       Impact factor: 4.742

8.  Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.

Authors:  Minqian Shen; Haifei Shi
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

9.  Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway.

Authors:  Kevin Y Guo; Lili Han; Xinyu Li; Andrew V Yang; Jiaxiong Lu; Shan Guan; Hui Li; Yang Yu; Yanling Zhao; Jianhua Yang; Hong Zhang
Journal:  Oncotarget       Date:  2017-12-12

10.  A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients' prognosis.

Authors:  Ting Lin; Jingxian Gu; Kai Qu; Xing Zhang; Xiaohua Ma; Runchen Miao; Xiaohong Xiang; Yunong Fu; Wenquan Niu; Junjun She; Chang Liu
Journal:  Aging (Albany NY)       Date:  2018-09-21       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.